Risk factors of mild cognitive impairment in middle aged patients with type 2 diabetes: A cross-section study

Annales d'Endocrinologie

Volumn 73, Issue 3, 2012, Pages 208-212

  Chen, Rui Hua ^a   Jiang, Xiao Zhen ^a   Zhao, Xiao Hui ^a   Qin, Yu Lan ^a   Gu, Zhe ^a   Gu, Pei Li ^a   Zhou, Bin ^a   Zhu, Zhen Hong ^a   Xu, Lin Yan ^a   Zou, Yu Feng ^a  

^a Pudong New Area People's Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIABETIC PATIENT; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; FAMILY HISTORY; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK FACTOR; SCORING SYSTEM; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; ANTHROPOMETRY; C-PEPTIDE; CAROTID INTIMA-MEDIA THICKNESS; CAROTID STENOSIS; CHINA; COMORBIDITY; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; OBESITY; PSYCHOLOGICAL TESTS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; VASCULAR RESISTANCE;

EID: 84863821108     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ando.2012.04.009     Document Type: Article

References (30)

1. Biessels G.J., Deary I.J., Ryan C.M. Cognition and diabetes: a lifespan perspective. Lancet Neurol 2008, 7:184-190.
2. Okereke O.I., Kang J.H., Cook N.R., Gaziano J.M., Manson J.E., Buring J.E., et al. Type 2 diabetes mellitus and cognitive decline in two large cohorts of community dwelling older adults. J Am Geriatr Soc 2008, 56:1028-1036.
3. Ryan C.M., Geckle M.O. Circumscribed cognitive dysfunction in middle-aged adults with type 2 diabetes. Diabetes Care 2000, 23:1486-1493.
4. Arvanitakis Z., Wilson R.S., Li Y., Aggarwal N.T., Bennett D.A. Diabetes and function in different cognitive systems in older individuals without dementia diabetes. Diabetes Care. 2006, 29:560-565.
5. Grodstein F., Chen J., Wilson R.S., Manson J.E. Type 2 diabetes and cognitive function in community-dwelling elderly women. Diabetes Care 2001, 24:1060-1065.
6. Petersen R.C. Mild cognitive impairment: current research and clinical implications. Semin Neurol 2007, 27:22-31.
7. Weiner M.F., Rosenberg R.N., Womack K.B., Svetlik D.A., Fuller C., Fields J., et al. Atherosclerosis risk factors in American Indians with Alzheimer disease: preliminary findings. Alzheimer Dis Assoc Disord 2008, 22:245-248.
8. Luis C.A., Keegan A.P., Mullan M. Cross validation of the Montreal Cognitive Assessment in community dwelling older adults residing in the Southeastern US. Int J Geriatr Psychiatry 2009, 24:197-201.
9. Zhao S., Guo C., Wang M., Chen W., Wu Y., Tang W., et al. A clinical memory battery for screening for amnestic mild cognitive impairment in an elderly chinese population. J Clin Neurosci 2011, 18:774-779.
10. Gauthier S., Reisberg B., Zaudig M., Petersen R.C., Ritchie K., Broich K., et al. Mild cognitive impairment. Lancet 2006, 367:1262-1270.
11. Shimada H., Miki T., Tamura A., Ataka S., Emoto M., Nishizawa Y. Neuropsychological status of elderly patients with diabetes mellitus. Diabetes Res Clin Pract 2008, 87:224-227.
12. Murthy S.B., Jawaid A., Schulz P.E. Diabetes mellitus and dementia: advocating an annual cognitive screening in patients with diabetes mellitus. J Am Geriatr Soc 2008, 56:1976-1977.
13. Petrova M., Prokopenko S., Pronina E., Mozheyko E. Diabetes type 2, hypertension and cognitive dysfunction in middle age women. J Neurol Sci 2010, 299:39-41.
14. Bruce D.G., Casey G.P., Grange V., Clarnette R.C., Almeida O.P., Foster J.K., et al. Cognitive impairment, phycical disability and depressive symptoms in older diabetic patients: the Fremantle Cognition in Diabetices Study. Diabetes Res Clin Prac 2003, 61:59-67.
15. Petersen R.C., Thomas R.G., Grundman M., Bennett D., Doody R., Ferris S., et al. Alzheimer's Disease Cooperative Study Group. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl Med 2005, 352:2379-2388.
16. Lee J.Y., Dong Woo Lee, Cho S.J., Na D.L., Hong Jin Jeon, Kim S.K., et al. Brief screening for mild cognitive impairment in elderly outpatient clinic: validation of the Korean version of the Montreal Cognitive Assessment. J Geriatr Psychiatry Neurol 2008, 21:104-110.
17. Mortimer J.A., Borenstein A.R., Ding D., Decarli C., Zhao Q., Copenhaver C., et al. High normal fasting blood glucose is associated with dementia in Chinese elderly. Alzheimers Dement 2010, 6:440-447.
18. Luchsinger J.A., Reitz C., Patel B., Tang M.X., Manley J.J., Mayeux R. Relation of diabetes to mild cognitive impairment. Arch Neurol 2007, 64:570-575.
19. Ebadya S.A., Aramib M.A., Shafigha M.H. Investigation on the relationship between diabetes mellitus type 2 and cognitive impairment. Diabetes Res Clin Prac 2008, 82:305-309.
20. Xiuying Qi, Xianhai Meng, Yun Xie, Dan Qian, Yuying Zhou, Xia Zhao, et al. Risk factors and predisposing genes for mild cognitive impairment in patients with type 2 diabetes mellitus. Alzheimers Dement 2010, 6:S453.
21. Hassing L.B., Hofer S.M., Nilsson S.E., Berg S., Pedersen N.L., McClearn G., et al. Comorbid type 2 diabetesmellitus and hypertension exacerbates cognitive decline: evidence from a longitudinal study. Age Ageing 2004, 33:355-361.
22. Restelatto L.M.F., Varela J.S., Costa A.L., Bombardelli K., Rosin E., Silva R.S., et al. Cardiovascular risk factors are directly correlated with the degree of cognitive decline in Mild cognitive impairment and Alzheimer's disease patients. Alzheimers Dement. 2011, 7:S325.
23. Franek E., Januszkiewicz-Caulier J., Błach A., Napora M., Jedynasty K., Budlewski T., et al. Intima-media thickness and other markers of atherosclerosis in patients with type 2 diabetes and periodontal disease. Kardiol Pol 2012, 70:7-13.
24. Gorgone G., Ursini F., Altamura C., Bressi F., Tombini M., Curcio G., et al. Hyperhomocysteinemia, intima-media thickness and C677T MTHFR gene polymorphism: a correlation study in patients with cognitive impairment. Atherosclerosis 2009, 206:309-313.
25. Pourcelot L. Applications clinique de l'examen Doppler transcutané. Symposium: velometric ultrasonnordoppler 1974, 213-240. Inserm, Paris. P. Peronneau (Ed.).
26. Grima P., Guido M., Chiavaroli R., De Donno A., Tana M., Zizza A. Comparison of intima-media thickness and ophthalmic artery resistance index for assessing subclinical atherosclerosis in HIV-1-infected patients. Cardiovasc Ultrasound 2011, 1:9.
27. Li Z.G., Qiang X., Sima A.A.F., Grunberger G. C-peptide attenuates protein tyrosine phosphatase activity and enhances glycogen synthesis in L6 myoblasts. Biochem Biophys Res Commun 2001, 280:615-619.
28. Zhen-Guo Li, Sima A.A.F. C-peptide and central nervous system complications in diabetes. Experimental Diabetes Res 2004, 5:79-90.
29. Okereke O.I., Pollak M.N., Hu F.B., Hankinson S.E., Selkoe D.J., Grodstein F. Plasma C-peptide levels and rates of cognitive decline in older, community-dwelling women without diabetes. Psychoneuroendocrino 2008, 33:455-461.
30. Sima A.A.F., Zhen-Guo Li. The effect of C-peptide on cognitive dysfunction and hippocampal apoptosis in type 1 diabetic rats. Diabetes 2005, 54:1497-1505.